Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Patient Initiation and Persistence With Advised Allergen Immunotherapy

NCT01549340 is registered in ClinicalTrials.gov with ALK-Abelló A/S as lead sponsor.

NCT NCT01549340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01549340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Patient Initiation and Persistence With Advised Allergen Immunotherapy
Lead sponsor
ALK-Abelló A/S
Phase
Observational
Overall status
Completed
Start date
November 30, 2011
Completion date
May 31, 2012
Enrollment
8,790 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

perennial allergic rhinitis, seasonal allergic rhinitis